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Abstract
Background: Vaccination was a core component for mitigating the 2009 influenza pandemic (pH1N1). However, a
vaccination program’s efficacy largely depends on population compliance. We examined general population decision-
making for pH1N1 vaccination using a modified Theory of Planned Behaviour (TBP).
Methodology: We conducted a longitudinal study, collecting data before and after the introduction of pH1N1 vaccine in
Hong Kong. Structural equation modeling (SEM) tested if a modified TPB had explanatory utility for vaccine uptake among
adults.
Principal Findings: Among 896 subjects who completed both the baseline and the follow-up surveys, 7% (67/896) reported
being ‘‘likely/very likely/certain’’ to be vaccinated (intent) but two months later only 0.8% (7/896) reported having received
pH1N1 vaccination. Perception of low risk from pH1N1 (60%) and concerns regarding adverse effects of the vaccine (37%)
were primary justifications for avoiding pH1N1 vaccination. Greater perceived vaccine benefits (b= 0.15), less concerns
regarding vaccine side-effects (b=20.20), greater adherence to social norms of vaccination (b= 0.39), anticipated higher
regret if not vaccinated (b= 0.47), perceived higher self-efficacy for vaccination (b= 0.12) and history of seasonal influenza
vaccination (b= 0.12) were associated with higher intention to receive the pH1N1 vaccine, which in turn predicted self-
reported vaccination uptake (b= 0.30). Social norm (b= 0.70), anticipated regret (b= 0.19) and vaccination intention
(b= 0.31) were positively associated with, and accounted for 70% of variance in vaccination planning, which, in turn
subsequently predicted self-reported vaccination uptake (b= 0.36) accounting for 36% of variance in reported vaccination
behaviour.
Conclusions/Significance: Perceived low risk from pH1N1 and perceived high risk from pH1N1 vaccine inhibited pH1N1
vaccine uptake. Both the TPB and the additional components contributed to intended vaccination uptake but social norms
and anticipated regret predominantly associated with vaccination intention and planning. Vaccination planning is a more
significant proximal determinant of uptake of pH1N1 vaccine than is intention. Intention alone is an unreliable predictor of
future vaccine uptake.
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Introduction
Influenza contributes significantly to worldwide morbidity and
mortality [1]. Periodically, influenza viruses mutate into antigen-
ically-different strains leading to global pandemics [2]. The 2009
influenza pandemic (pH1N1) was caused by a triple reassortment
of human, swine and avian influenza viruses [3]. Vaccination is the
most effective intervention for preventing influenza [4] and a core
part of national pandemic plans for pandemic mitigation. Lead
times of at least 6 months in producing a vaccine against a novel
strain means that while vaccines may be unavailable in time to
prevent the first wave of a pandemic [5,6], effective public uptake
of a vaccine may mitigate subsequent waves [7].
Background
Significant health promotion activities regarding influenza
prevention have been prominent in Hong Kong since well before
the onset of pH1N1, arising largely from the Severe Acute
Respiratory Infection (SARS) epidemic and A/H5N1 Bird Flu
outbreaks. Seasonal influenza vaccination is widely promoted each
year. Hong Kong’s pH1N1 epidemic started on 11 June 2009,
peaking in September, and by early November had petered out
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(Figure 1). By the end of December 2009, the Hong Kong
government had recorded 37,174 human pH1N1 cases [8] in a
population of,7 million. To minimize any potential second wave,
significant televised and other publicity was given to the launch of
a pH1N1 vaccination programme on 21 December 2009, initially
for five priority groups: healthcare workers, persons with chronic
illness and pregnant women, children aged 6 months to 6 years,
adults aged 65 years or above, and pig farmers and slaughtering
industry personnel [9]. On 26 January 2010 pH1N1 vaccination
was extended to the general public. The vaccination was free for
priority group members [10], but cost HK$100–150 (US$13–20,
1–1.5% of Hong Kong’s median monthly income of HK$10,000/
US$1,286/J991) per dose for the general population. A study in
July 2009 of 301 respondents projected that vaccine uptake would
be influenced by end-user cost, with 45%, of Hong Kong’s general
population being ‘‘highly likely’’ to take up pH1N1 vaccine if free,
and 24% if costing HK$100–200 (US$13–25) [11,12].
From November 2009 onwards, television, radio, newspaper
and official websites strongly encouraged priority groups to have
pH1N1 vaccination [13]. However, the Hong Kong government
did not make recommendations for the general population, who
were asked to judge for themselves whether to be vaccinated or
not. Shortly after the vaccine launch for priority groups, local
media prominently attributed several adverse events to pH1N1
vaccination, including, a case of Guillain-Barre Syndrome (GBS)
diagnosed a week after pH1N1 vaccination, reported on 6th
January 2010, and an intrauterine death (IUD) 3 weeks following
the mother’s vaccination, reported on 20th January 2010
(Figure 2). In both cases local health agencies presented convincing
evidence challenging the link between vaccination and the two
adverse events but were largely ignored. Retrospectively, a drop in
pH1N1 vaccination uptake among priority groups was observed
[14]. It seems probable that the adverse media reports had
impeded vaccination uptake among general population. We
collected baseline data between 12–25 January, 2010, immediately
before pH1N1 vaccine was made available to the general
population and then two months later (15–30 March 2010) we
recorded their reported vaccination status (Figure 2) with the
intention of modelling how general population decision-making
regarding pH1N1 vaccination might predict subsequent vaccine
uptake.
Previous findings and knowledge gap
Empirical studies have found that history of seasonal influenza
vaccination [12,15–18], perceived risk of pandemic influenza
[17,19–26], worry [17,22,26,27], and attitudes towards vaccine,
such as vaccine efficacy and side-effects [12,15,20,24–26] were
significantly associated with intention to receive a vaccine against
the influenza pandemic. This is consistent with the findings related
to determinants of vaccination against seasonal influenza [28–32].
However, there are some common and significant limitations to
these empirical studies. First, all except one [24] relied on
vaccination intention to predict the actual vaccination uptake. In
one study, since only a few respondents reported having received
the pH1N1 vaccine, the authors combined those intending to get
vaccinated with those who had already received the vaccine into
one ‘‘intending’’ group and examined factors associated with this
‘vaccination intention’ [20]. This is problematic because factors
associated with vaccination intention and actual vaccination
receipt probably differ. Moreover, the reliability of intention as a
predictor of actual behavior remains controversial. Harris et al.
found that only about half of ‘‘intending’’ recipients of seasonal
influenza vaccination actually take it and almost all those who do
not intend to take it remained unvaccinated [33]. Moreover, most
studies conducted before the pandemic occurred or before the
vaccine was available [11,12,16–19,21,23] reported relative high
intentions for vaccination against pandemic influenza among study
respondents. For example, in April–May, 2009, 65.5% and 94.6%
Figure 1. Epidemic curve showing the monthly reported human pH1N1 cases in Hong Kong. Data source: Center for Health Protection
Hong Kong government. Available at http://www.chp.gov.hk/en/dns_submenu/10/26.html.
doi:10.1371/journal.pone.0017713.g001
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of Dutch respondents reported intending to take pH1N1
vaccination prior to or at the onset of the (potential) pandemic
phase, respectively [23]. Similarly, in Hong Kong 45% of 301
respondents in July 2009 reported being ‘‘highly likely’’ to receive
pH1N1 vaccine if offered for free [11,12]. However, by the time
vaccination became available intention appeared much lower with
only 10–15% of study respondents in France and in Turkey
intending to take the pH1N1 vaccine [20,24]. Second, all the
studies are cross-sectional rather than longitudinal; none assessed
subsequent actual vaccination status. Thus, although associations
have been identified, there is no way to infer causality. Third, most
of the studies are atheoretical. Although some of the studies
developed their study questions based on theoretical framework
such as HBM [17,23,24], none have conducted model analysis
and evaluated the model fit. Therefore, due to these three reasons,
there remains a significant concern about how valid such results
are and a significant knowledge gap about how the observed
pattern of influences could be explained.
Intention-behaviour relation
A major limitation of previous empirical studies [12,15–
23,25,26] is failure to accommodate the intention-behaviour
gap. Although several behavioral theories such as Protection
Motivation Theory (PMT) [34,35], Theory of Reasoned Action
(TRA) [36,37] and Theory of Planned Behaviour (TPB) [38,39]
propose that intention is the proximal determinant of behaviour,
intention does not necessarily translate into actual behaviour.
Empirical studies of the intention-behavior relationship showed
that intention had a medium effect (a correlation of ,0.4–0.5) on
behavior [40–42], but a recent review including 47 experimental
studies found that a medium-to-large change in intention induced
by manipulated interventions caused only a small-to-medium
change in behavior [43], where an effect size of 0.5 is medium and
one of 0.2 is small [44]. Sheeran found that about 47% of those
intending to take action fail to act [42], consistent with Harris et
al’s findings [33]. Factors that are prime contenders to moderate/
mediate the relationship between intention and behaviour include
behavioural control/efficacy, action planning and anticipation of
consequences [41–43].
Perceived behavioural control/self-efficacy. The TPB is
an extension of the TRA incorporating the concept of perceived
behavioural control (PBC) as an intervening variable predicting
both intention and also actual behavioural change directly
[38,39]. The direct effect of PBC on actual behavioural change
partly explains why not all intention translates into behaviour.
Previous reviews suggested that intention-behaviour relationships
could be moderated by perceived behavioral control, with higher
levels of perceived behavioural control improving prediction of
intention on behaviour [42,43]. Although some researchers
suggested that PBC differs from self-efficacy because self-
efficacy emphasized perceived internal control more while PBC
also considers external control factors [45], a systemic review on
the efficacy of TBP found that PBC and self-efficacy had
comparable effects on intention and behaviour [41]. Despite
being a dominant theory of behavioural change, because the TPB
is limited in predicting behaviour we sought to enhance its
predictive power by replacing PBC with self-efficacy and
incorporating enhanced social effects to accommodate external
control factors.
Implementation of intention/planning. Implementation
of intention, termed ‘‘planning’’, is a potentially important factor
facilitating translation of intention into behaviour [42,43,46,47].
Planning is specific to situations (e.g., when, where, and how)
within which one will perform the behaviour [46]. It activates the
situational context for goal attainment and thereby makes the goal
become more accessible [46,47]. A meta-analytic review showed
that implementation of intention as planning consistently caused a
medium-to-large effect on behavioural change [47].
Anticipated regret. Anticipated regret is the expectation of
feeling regret or upset if one does or does not conduct certain
behaviours. Anticipated regret has been found to be a strong
predictor of vaccine uptake against seasonal influenza [31,32],
playing the lottery [48] and exercise [49]. Anticipated regret might
also moderate the intention-behavior relationship: the higher
anticipated regret for inaction, the better the prediction of
intention on behaviour [48,49].
Our conceptual model
A robust theoretical framework comprehensively explaining
behavior change that elucidates population decision-making for
health protective and promoting behaviour has long been sought.
As the main contender, the TPB explains ,34% of variance in
Figure 2. A chronology of events about the pH1N1vaccine availability, reporting of potential vaccine-related adverse events and
conducting of the current study.
doi:10.1371/journal.pone.0017713.g002
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health behavioural change related to addictive behaviour,
automobile-related behaviours, clinical and screening behaviour,
eating behaviour, exercising behaivour, HIV/AIDS-related be-
haviour and oral hygiene behaivour [40]. The standard version of
TPB proposes that attitudes towards the behaviour, subjective
norm and PBC predict behavioral intention while intention and
PBC predict the actual behavioural change [38,39]. Additional
predictors that significantly improve the model’s predictive power
are needed [39]. Two previous studies have examined modified
versions of TPB to predict vaccination uptake against seasonal
influenza [50,51]. One study used TPB plus two additional factors:
influenza vaccination history and anticipated regret, to predict
intention to receive vaccine against seasonal influenza among
elderly from social clubs [50]: vaccination history and anticipated
regret respectively accounted for an additional 10.7% and 13.7%
of total variance in influenza vaccination intention [50]. However,
again the study was cross-sectional and actual vaccination uptake
was not assessed. A second study of healthcare workers [51]
adopted an extended version of TPB that included additional
elements of anticipated regret, moral norm, descriptive norm and
professional norm. The study found that controlling for the
original TPB variables, moral norm and anticipated regret were
significant determinants of actual receipt of seasonal influenza
vaccine [51]. The study provides useful information for future
application of the extended version of TPB. However, since the
study was conducted among healthcare workers, some of the
variables such as moral norm and professional norm which
emphasize obligation and professional convictions may not be
applicable among the general population.
Factors influencing pH1N1 vaccine uptake at the later stage of a
pandemic might be more cognitively driven unlike behavioral
responses during the early stage of a pandemic which might be
more affect driven [52]. Therefore, taking into account prior work
on seasonal influenza vaccination uptake [50,51], extending the
TPB could provide theoretical utility for understanding public
decision on taking pH1N1 vaccination. Starting with TPB and
existing literature, we therefore built a conceptual model of public
decision-making for pH1N1 vaccination (Figure 3). In addition to
the original TPB components, seasonal influenza vaccination
history, anticipated regret and vaccination planning were included
in the model. The model proposed that attitudes towards
vaccination (perceived benefits of pH1N1 vaccination and
concerns regarding possible adverse effects of pH1N1 vaccination),
perceived social pressures from significant others and other people
around regarding pH1N1 vaccination (social norms regarding
pH1N1 vaccination), perceived self-efficacy in taking vaccination
(perceived self-efficacy), anticipated regret for not taking the
pH1N1 vaccination (anticipated regret) and seasonal influenza
vaccination history would predict vaccination intention, which in
turn predicts vaccination planning and future vaccination uptake;
anticipated regret and perceived self-efficacy could also predict
vaccination status directly; finally, vaccination planning was
proposed to bridge the intention-behavior gap and predict
vaccination status directly (Figure 3).
We conducted a longitudinal study of influences on pH1N1
vaccination behaviour in Hong Kong to test this model (Figure 3),
and subsequently followed up participants to record their self-
reported receipt of pH1N1 vaccine. In this study, we aimed to
answer the following research questions: How well does intention
predict future uptake of pH1N1 vaccine? Does vaccination
planning mediate the relation between intention and future
vaccination uptake? And do the original TPB components and
the additional components (extended social norms, anticipated
regret and seasonal influenza vaccination history) contribute to
peoples’ decisions on vaccination uptake?
Figure 3. An extended Theory of Planned Behaviour.
doi:10.1371/journal.pone.0017713.g003
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Methods
Ethics statement
The study obtained ethics approval from the Institutional
Review Board of the University of Hong Kong/Hospital Authority
Hong Kong West Cluster. Written informed consent was waived
by the IRB because all the data were analyzed anonymously, but
verbal consent was obtained from all the subjects before the
interview started.
Sampling
Hong Kong has 99% landline telephone penetration, local calls
are free and telephone interviews are common and representative
methods of survey data collection [53]. We conducted 13 main
cross-sectional telephone surveys of psychological and behavioural
responses to the first wave of the 2009 influenza A/H1N1
pandemic in Hong Kong from April through November 2009 (the
parent study) [53] in order to monitor these variables. As an
extension, the present study re-contacted subjects from some of
these surveys and sought to understand public decision-making
regarding pH1N1 vaccine uptake for mitigating the potential
second wave of the pandemic. Between 12–25 January, 2010 a
baseline assessment for the present study was performed,
immediately prior the local pH1N1 vaccination campaign
extending to the general community (vaccination for high risk
groups started from December 21, 2009), and we again contacted
participants for follow-up two months later, between 15–30 March
2010.
Sample size determination. We estimated that a sample of
at least 500 was required to achieve 80% power at an a=0.05 to
reject a model of the specified complexity (Figure 3) if the model fit
index Root Mean Square Error of Approximation (RMSEA)
exceeded 0.08 [54,55]. To allow for a response rate ,60% in the
follow-up and the baseline surveys, we need to target at least 1,389
subjects in the baseline survey.
Subject selection and inclusion criteria. A flow chart
showing subject selection is provided in Figure 4. A total of 12,965
subjects participated in the parent study [53]. All these subjects
were Cantonese-speaking adults (aged$18) selected within
households using a Kish Grid methodology, who were capable
of and willing to answer a telephone interview. Additional details
about inclusion criteria are available elsewhere [53]. Respondents
in the 7th, 9–12th surveys of the 13 surveys comprising the parent
study who, in the parent study agreed to be re-contacted and who
had not received pH1N1 vaccine were invited to complete the
baseline assessment for the present study. These five surveys (the
7th, 9–12th surveys) were selected because participants in these
surveys had not had any follow-up contact either in the parent
study or otherwise. This minimizes interview fatigue thereby
improving response rates. These surveys were all of a comparable
Figure 4. Flow chart of sampling.
doi:10.1371/journal.pone.0017713.g004
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sample size, between 1,000–1,007 [53]. The five selected surveys
were conducted between 21 July and October 23, 2009, and
generated a representative [53] pool of 5,014 respondents of
whom 61.4% (3,079/5,014) gave consent for further contact.
From a list of the 3,079 subjects who agreed to be re-contacted,
1,648 calls were randomly selected and successfully made by a
university telephone polling organization. Unanswered calls were
tried at least four times at different hours and weekdays before
being replaced by new numbers. Finally, a total of 1,511 (92%,
1,511/1,648) respondents agreed to participate in the baseline
survey. Of these 78 (5%, 78/1,511) reported already having
received pH1N1 vaccination and were therefore excluded as
ineligible, leaving 1,433 respondents who completed baseline
interviews.
Data collection
The interview questionnaire for the baseline survey was derived
from literature review, our previous cross-sectional surveys [53]
and the theoretical framework constructed for this study (Figure 3).
Specialists in health psychology, statistics, infectious disease and
public health jointly determined the measures comprising the final
questionnaire, guided by the need to maintain low assessment load
and parsimony to ensure good response rates. The finalized
questionnaire consisted of five sections: Section 1 addressed
respondents’ self-rated health and their experience of influenza-
like illness in the past six months; Section 2 addressed risk
perceptions regarding pH1N1; Section 3 addressed perceived trust
in information related to pH1N1 and pH1N1 vaccination from
different information sources; Section 4 addressed attitudes, beliefs
and social norms regarding pH1N1 vaccine/vaccination, vacci-
nation intention and planning; Section 5 addressed key respondent
demographics. Overall, the baseline assessment consisted of 44
questions, which took less than 15 minutes to complete. Other
demographic data were obtained from the parent study [53]. Prior
to baseline assessment for the present study, subjects were
reminded of their prior participation and that they had agreed
to participate in a further study. The study was introduced as a
survey of attitudes towards swine flu vaccination. We sought their
willingness to participate. Those agreeing were asked about their
vaccination status. Subjects who reported that they had already
received pH1N1 vaccination were excluded. The remaining
interview was performed. A follow-up survey was conducted 2
months later wherein respondents were reminded of the earlier
survey and asked about their vaccination status and reasons for
having had or not having vaccination. All the data were collected
through telephone interview in both Baseline and Follow-up
surveys.
Measures
The measures comprising the study instruments were used to
build the conceptual model (Figure 3) and are described below and
in Table 1.
Perceived benefits of pH1N1 vaccination, and, Concerns
regarding adverse effects of pH1N1 vaccination. These two
constructs assessed attitudes towards pH1N1 vaccination.
Perceived benefits of pH1N1 vaccination was assessed by
measuring agreement on five-point ordinal scales (from 1
‘‘strongly disagree’’ to 5 ‘‘strongly agree’’) with three statements
(Table 1). A Cronbach’s alpha (a) of 0.71 indicated an acceptable
internal consistency for this scale and these two items were treated
as the indicators of a latent scale (Perceived benefits of pH1N1
vaccination). Concerns regarding adverse effects of pH1N1
Table 1. Items, response scales and internal consistency for assessing measures of model.
Measures Items Response scales aa
Perceived benefits of pH1N1 vaccination I believed that the HSIb vaccine can protect me against HSI. 1–5 agreement 0.71
I believe that it will help to protect my family or friends against
HSI if I take the HSI vaccination
1–5 agreement
I believe that the HSI vaccination can reduce my risk of contracting HSI. 1–5 agreement
Concerns regarding adverse effects
of pH1N1 vaccination
I fear that the HSI vaccination will cause some unpleasant side effects. 1–5 agreement 0.64
I worry that the vaccine may cause more harm than the flu 1–5 agreement
Social norms regarding pH1N1 vaccination Other people going to take HSI vaccination will encourage me to go. 1–5 agreement 0.53
My family and friends think that it is important for me to take
vaccination against HSI
1–5 agreement
Anticipated regret If you decide not to take the HSI vaccination this winter, how
likely will you regret your decision?
1–7 likelihood 0.68
If you decide not to take the HSI vaccination this winter, and later you
were infected with HSI and infect other household members, then
how likely do you think it is that you will regret your decision?
1–7 likelihood
Perceived self-efficacy I am confident that I can go independently to get HSI vaccination. 1–5 agreement -
Seasonal influenza vaccination history Have you received seasonal influenza vaccination? Yes/No -
Vaccination intention How likely is it that you are going to have the HSI vaccination this winter? 1–7 likelihood -
Vaccination planning I have planned when and where to get my HSI vaccination this winter. 1–5 agreement 0.59
When vaccines are available I intend to discuss with my doctor if s/he
thinks it is good for me to have the vaccination
1–5 agreement
I have discussed with my family about my plan for HSI vaccination 1–5 agreement
aChronbach’s a indicates the internal consistency.
bHSI represent Human Swine influenza, the local colloquialism for pH1N1.
doi:10.1371/journal.pone.0017713.t001
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vaccination were assessed by measuring agreement, using five-
point scales, with two statements. The Cronbach’s a for these two
items was 0.64, considered acceptable by some researchers [56],
though clearly less than desirable. We therefore treated the items
as reflecting a latent variable (Concerns regarding adverse effects
of pH1N1 vaccination).
Social norms regarding pH1N1 vaccination. While TBP
considers the influence of solely coercive social pressure from
significant others to perform a behaviour, previous studies suggest
that it is also important to consider the generalized tendency to
adopt behaviours demonstrated by others encountered in daily life
for imitative reasons [48,57]. We use the term Social norms rather
than subjective norm to represent these broader coercive and
imitative social influences. Social norms were assessed by
agreement on a 5-point scale with two statements. The internal
consistency for these two items was weaker, with a=0.53, which
suggests each item appropriately measures different social
influences. We initially incorporated these items separately in the
structural equation model but except for the path weights dividing
almost equally between the two items, no difference was otherwise
seen. We therefore retained them as indicators of a combined
latent construct in the model for purposes of model parsimony
[58].
Anticipated regret. Anticipated regret was assessed with two
statements asking about respondents’ likelihood of feeling regret.
Responses of these two items were on a 7-point categorical scale
(from 1 ‘‘definitely not’’ to 7 ‘‘certain’’). The internal consistency a
for these two items was 0.68. The two items were used to indicate
the latent variable ‘‘anticipated regret’’ in the modeling analysis.
Perceived self-efficacy. One item was used to measure self-
efficacy, asking about respondents’ agreement on a 5-point scale
with the statement ‘‘I am confident that I can go independently to
get human swine flu vaccination’’. A standard scale of self-efficacy
was not adopted to minimize assessment load. However, a single
item for self-efficacy has been shown elsewhere to have validity in
predicting behavioural change [59,60].
Seasonal influenza vaccination history. Respondents were
asked whether they had received any seasonal influenza
vaccination in the past three years (Yes/no/don’t know).
Vaccination intention. Respondents were asked how likely it
was that they would get vaccinated against pH1N1 during the
winter flu season, using a 7-point Likert scale (from 1 ‘‘definitely
not’’ to 7 ‘‘certain’’).
Vaccination planning. We measured vaccination planning
by assessing respondents’ agreement on a 5-point scale with three
statement items, such as ‘‘I have planned when and where to get
my human swine flu vaccination this winter’’. The internal
consistency a for these three items was 0.59, though less than the
most common acceptable level of above 0.7, remaining at the
minimal acceptable level (a ranged between 0.5–0.6) of reliability
for preliminary research [56]. These items were also treated as
indicators of a latent variable for modeling purposes.
Reported vaccination uptake. In the follow-up survey,
respondents were asked to confirm if they had received pH1N1
vaccine within the past three months. Respondents were also asked
to indicate their major reasons for having or not having taken the
pH1N1 vaccination using open-ended questions. Multiple reasons
could be given by each respondent.
Statistical analysis
We first compared demographic differences between follow-up
and lost-to-follow-up respondents with Pearson chi-square test
while demographic differences of the respondents who completed
both the baseline and follow-up survey and the general population
[61] were assessed using Cohen’s effect sizes [44]. Proportions
were calculated to describe patterns of vaccination intention,
reported vaccination uptake, and major reasons for taking or not
taking pH1N1 vaccination. Structural equation modeling was then
applied to examine the determinants of pH1N1 vaccination,
vaccination intention and vaccination planning based on the
extension of TBP. Mplus 6.0 for Windows (Muthe´n & Muthe´n,
1998–2010) was employed because the model comprised dichot-
omous (vaccination status) and ordinal (vaccination intention)
outcome variables. Before testing the full structural model, zero-
order correlations between the measures of related constructs were
calculated. Confirmatory factor analysis was performed to assess
the adequacy of the measurement model including perceived
benefits of pH1N1 vaccination, concerns regarding adverse effects
of pH1N1 vaccination, social norms regarding pH1N1 vaccina-
tion, anticipated regret and vaccination planning. To test the full
structural model, all variables were entered into the model
simultaneously. Mean and variance adjusted weighted least
squares estimation was applied to evaluate the standardized
parameters (beta, b). Since chi-square test is very sensitive to
sample size and non-normally distributed data, several other
model fit indices were evaluated including the Comparative Fit
index (CFI), the Tucker Lewis index (TLI), and RMSEA. A
CFI.0.90 and TLI.0.90 indicates a good fit. RMSEA less than
0.05 and one ranging between 0.05–0.08 respectively indicate a
good and acceptable model fit [55]. Misfitting models were re-
specified guided by theoretical soundness and modification indices
[55]. Missing proportions ranged from 0.1% for seasonal flu
vaccination history to 5.5% for the item ‘‘I have planned when
and where to get my pH1N1 vaccination this winter’’. There was
no missing data for reported vaccination uptake. Missing data
were handled with multiple imputation [62].
Results
Participants
Of the 1433 respondents who completed the baseline
assessment, 896/1433 (63%) respondents agreed to participate
and completed the March follow-up survey (Figure 4). Demo-
graphic characteristics of respondents in the baseline and follow-
up surveys are shown in Table 2. Compared to respondents
completing both baseline and follow-up surveys, respondents lost
to follow-up were younger (x2 = 14.24, p= 0.001) and more likely
to be single (x2 = 20.26, p,0.001). Overall, the low Cohen effect
sizes (,0.3) showed that the demographics of respondents who
completed both the baseline and follow-up surveys were
comparable to those of the general population of Hong Kong [61].
Vaccination intention at baseline and vaccination status
at follow-up
Of the 1,433 respondents who completed the baseline survey,
36% (510/1,433) reported that they would ‘‘definitely not’’ take
pH1N1 vaccination during the winter flu season; 36% (521/1,433)
reported being ‘‘very unlikely/unlikely’’ to take it; 19% (278/
1,433) reported their pH1N1 vaccination likelihood as ‘‘evens’’
(50:50/equal likelihood); and only 8% (119/1,433) reported
vaccination likelihood as ‘‘likely/very likely/certain’’. Within the
subset of 896/1,433 respondents who completed both baseline and
follow-up surveys, 7% (67/896) had reported at baseline that they
would be ‘‘likely/very likely/certain’’ to receive pH1N1 vaccina-
tion. However, in the follow-up survey, only 7/896 (0.8%)
respondents reported having received pH1N1 vaccination in the
intervening period, 4 of whom had reported being ‘‘likely/very
likely/certain’’ to receive pH1N1 vaccination at baseline.
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Reporting higher intention to receive pH1N1 vaccination in the
baseline was associated with greater likelihood to vaccinate by
follow-up (Fisher’s exact test, x2 = 24.24, p,0.001).
Major reasons for receiving pH1N1 vaccine
The 7 respondents who reported taking pH1N1 vaccination
gave the major reasons for deciding on vaccination as follows:
Three choose vaccination because of the ‘high risk of swine influenza’
characterized by statements like ‘‘swine flu is serious’’, ‘‘I am
worried that swine flu will become more serious’’, and ‘‘I feel
vulnerable to swine flu’’; two reported that their decision was due
to ‘doctors’ advice’ and two reported ‘belief of the vaccine efficacy’. Other
reasons provided by one respondent only were ‘belief in the vaccine’s
safety’, ‘government recommendation’, ‘convenient availability’, and ‘protection
of patients’.
Major reasons for not receiving pH1N1 vaccine
Reasons for not having vaccination given by the 889
respondents who did not receive pH1N1 vaccination (Figure 5)
were, most frequently ‘low risk of or from swine influenza’ (529/889,
60%) and ‘concerns regarding adverse effects of the vaccine’ (328/889,
37%). Around 11% (100/889) of the respondents reported both
‘low risk of/from swine influenza’ and ‘concerns regarding adverse effects of
the vaccine’.
Structural equation model for receipt of pH1N1 vaccine
Table 3 presents the means, standard deviations, factor loadings
and correlations between the construct measures in the full
structural equation model. All the standardized factor loadings
exceeded 0.49 and were statistically significant. The model fit
indices for the measurement model indicated a good fit with
CFI= 0.95, TLI= 0.93, and RMSEA=0.05.
For the final full structural model (Figure 6), two additional
paths were added and estimated based on the modification
indices including a path from social norms to vaccination
planning and path from anticipated regret to vaccination
planning while the path from perceived self-efficacy to
vaccination and the path from anticipated regret to vaccination
were removed, coefficients for these two paths being non-
significant and too small to be meaningful. The final model
indicated a good fit with CFI = 0.96, TLI = 0.93 and
RMSEA= 0.06 (Figure 6).
The model showed that respondents perceiving greater
pH1N1vaccination benefits (b=0.15), less concerns regarding
vaccine adverse effects (b=20.20), greater sensitivity to social
norms b=0.39), higher anticipated regret if not vaccinated
(b=0.47), higher perceived self-efficacy in taking pH1N1
vaccination (b=0.12) and receiving seasonal influenza vaccination
in the past three years (b=0.12) reported greater intention to take
pH1N1 vaccination, and accounted for 59% of variance in
vaccination intention scores. Greater adherence to social norms
(b=0.70), higher vaccination intention (b=0.31) and higher
anticipated regret (b=0.19) were associated with more vaccination
planning, together accounting for 67% of variance in vaccination
planning. Both vaccination intention (b=0.30) and vaccination
planning (b=0.36) significantly predicted actual pH1N1 vaccina-
tion, accounting for 36% of variance in pH1N1 vaccination
(Figure 6).
Table 2. Comparison of the demographics of respondents and non-respondents in the follow-up survey.
Demographics Baseline (n =1433) Follow-up (n=896) Lost to follow-up (n=537) x2a Effect sizeb
Gender (Female) 63% 63% 63% 0.038 0.22
Age group
18–34 26% 23% 31% 14.24c 0.22
35–54 45% 45% 44%
$55 29% 32% 25%
Education level
Primary or below 15% 15% 14% 3.40 0.27
Secondary 51% 52% 49%
Tertiary or above 34% 32% 37%
Marital status
Single 31% 27% 38% 20.26c 0.11
Married 64% 68% 56%
Divorced/separated/widowed 5% 5% 6%
Birth place (Born in Hong Kong) 71% 71% 72% 0.37 0.22
Household income
#10,000 21% 21% 20% 6.45 -
10,000–20,000 27% 29% 23%
20,000–30,000 21% 21% 22%
$30,000 31% 29% 34%
aDemographics differences between follow-up respondents and those who were lost to follow up.
bEffect sizes w are calculated via the formula w~
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Xm
i~1
(p0(i){p1(i))
2
p0(i)
vuut , where p0 ið Þ and p1 ið Þ are the observed proportions in the i’th category from the 2006 Hong Kong
by-census data and the follow-up data, respectively.
cp,0.01.
doi:10.1371/journal.pone.0017713.t002
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Discussion
The World Health Organization recommended a stepwise use
of pH1N1 vaccines for protecting people against the pH1N1
influenza pandemic in July 2009 [63]. However, a vaccination
program’s efficacy largely depends on the public’s compliance.
Our study found that only 5% of 1,511 subjects reported having
received pH1N1vaccination and of 1,433 subjects remaining
unvaccinated, only 8% reported intending (being likely/very
likely/certain) to take the pH1N1 vaccine. Two months later in
the follow-up survey, an even smaller proportion, 0.8% of the
respondents who completed both the baseline and follow-up
survey reported having been vaccinated against pH1N1. Perceived
low risk of pH1N1 and concerns regarding vaccine-related adverse
effects were the two most frequently cited reasons for refusing the
vaccination. The extended TPB model suggests that both the
original TPB components and the additional components
contribute to people’s decisions on vaccination uptake but that
social norms and anticipated regret for not taking vaccination were
the strongest determinants of vaccination intention and vaccina-
tion planning. Finally vaccination planning partially-mediated the
relation between intention and reported vaccination uptake.
Compared to previous studies, vaccination intention was much
lower in our study than that found in surveys conducted prior to
the influenza pandemic [23] or before the vaccine was available
[11], but was comparable to the findings of surveys conducted in
France [20] and Turkey [24] after pH1N1 vaccination pro-
grammes were launched there. An earlier Hong Kong study that
relied on expressed intent to predict vaccination uptake [11] failed
to accurately predict the subsequent meager population uptake of
pH1N1 vaccination by, at best, an order of magnitude [64],
suggesting that intention alone is insufficient for predicting future
vaccination uptake, consistent with empirical findings in other
areas [33,42].
Despite predictions that intended pH1N1 vaccination uptake
would decline if there was insufficient data on novel vaccine safety
and efficacy [11], safety issues were not the predominant barrier to
vaccination in the present study. While 37% of our study
respondents who remained unvaccinated cited vaccine safety
concerns, despite good evidence that the vaccine is effective with a
risk profile similar to that of seasonal influenza vaccine [65],
almost twice as many, 60%, cited ‘low risk of/from swine
influenza’ as their reason for not getting vaccinated, suggesting
that these respondents felt no advantage would be gained by
vaccination. Around 11% of respondents, cited both ‘low risk of/
from swine influenza’ and ‘concerns regarding adverse effects of
vaccine’ as the reasons for not getting vaccinated, seemingly
adopting a risk-benefit approach to vaccination decision-making.
However, in the setting of low influenza risk, with the reports of
vaccine related adverse events in the media after the vaccine was
available for the priority groups (Figure 2), people may shift their
perceived risks away from influenza and towards vaccination,
suggestive of availability bias (risk distortion by easily recalled
events) [66]. We believe that perceived vaccine risk would become
progressively less of a barrier to vaccination as perceived influenza
risk increases, and vice versa.
Moreover, despite recent reports that Hong Kong residents
would be sensitive to vaccination pricing when considering
whether to vaccinate [11,12], only 2.5% of our respondents cited
high vaccine cost as the reason for rejecting vaccination.
Major reasons for taking pH1N1 vaccination corresponded to
reasons for not taking it, with perception of pH1N1 risk most
frequently cited. However, the few respondents receiving pH1N1
vaccination prohibited meaningful comparison.
The extended version of TPB model fits well to the survey data.
The model showed that an expanded social norms and anticipated
regret accounted for most of the variance in vaccination intention,
rather than the more core elements of TPB. In turn, social norms
independently accounted for more than twice the variance in
vaccination planning than did intention, and vaccination planning
accounted for more variance in vaccination uptake than did
intention. Thus it seems that social norms comprise the major
influences on vaccination uptake through modifying vaccination
intention and planning. A meta-analytic review of TPB efficacy
concluded that the TPB variable subjective norm (perceived
coercive social pressure from significant others) weakly predicted
intention compared to other TPB components, mainly due to poor
measurement [41]. ‘‘Descriptive norm’’ (perception of what other
people do, imitation or conformity behaviour) is reportedly a more
important predictor for intention [48,57]. Here we combined
Figure 5. Major reasons for rejecting pH1N1 vaccination among respondents who reported not receiving pH1N1 vaccination.
doi:10.1371/journal.pone.0017713.g005
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measures of subjective and descriptive norms, treated as a latent
variable (social norms), because they were found to have much the
same predictive direction and weight. Multiple item measures of
norms should have better predictive power than single item
measures [41].
This model importantly informs public health approaches to
population behaviour during respiratory epidemics. First, infor-
mation uncertainty or untrustworthiness, for example regarding
vaccine safety, is likely to prompt people look to others for their
cues to action: the social environment, namely what other people
believe and do powerfully influences decisions to action [45,67].
People often tend to imitate others, so establishing a ‘‘vaccination
trend’’ may help uptake. For example, it could be effective to
encourage those who remain unvaccinated with feedback from
vaccinated peers and by providing an updated total of numbers
vaccinated. What the general public think and do may prove to be
as influential as information from scientists or health professional
[68,69]. Second, encouraging uptake of a new vaccine will be
problematic if the associated threat element is low, irrespective of
vaccine pricing, particularly for novel and untested vaccines.
Vaccine safety and efficacy data should be provided wherever
possible at all levels including through health-care providers,
media and the general public. To effectively communicate the risk
and benefit of a novel vaccine, it is important to establish an
effective surveillance system to monitor vaccination progammes
and rapidly respond to any reported adverse events [70]. The
media have an important influence and both reactionary and
opinionated news items should be recognized as potentially
detrimental to vaccination uptake. In particular, the need to
develop stories that generate revenue increasingly overrides
balanced reporting in contemporary media. Hence risk amplifi-
cation remains a problem. Public health agencies need to improve
their liaison with influential media outlets to minimize this, where
possible. Third, omission bias, a phenomenon where people view
vaccination as more risky than remaining unvaccinated, could be a
barrier for vaccination [71]. Omission bias arises when there is
anticipation of greater regret about adverse effects of vaccination,
if taken, than the regret about being infected with influenza if
vaccination is rejected [72]. Therefore, social marketing empha-
sizing the far greater likelihood of regret for consequences due to
refusing vaccination than the regret over an improbably low
adverse event due to taking vaccination may help to reduce this
bias. For example, previous studies found that simply asking two
questions about feeling regret for inaction could increase
respondents’ intention to play a lottery or do exercise [48,49].
Finally, vaccination planning is a key intervening variable between
vaccination intention and actual vaccination. This is to be
expected given that it is more proximal to actual behaviour than
intention is. In those who may be undecided, interventions
facilitating planning may prompt action. This could include
suggesting where, when and how to get vaccination, improving
and publicizing accessibility of vaccination centres and opening
times. Even so, intention and planning explained only 36% of the
variance in the reported vaccination behaviour, suggesting that
other factors, such as intention stability [42], influencing
vaccination behaviour await identification.
Study limitations include baseline attitudes/beliefs, vaccination
intention and planning being measured at the same time point,
prohibiting exploration of causality in observed associations. Some
study measures were constrained due to length of telephone
interviewing, and while sub-optimal were necessary methodolog-
ical compromises. Although most researchers recommended
Cronbach’s a of 0.7 as the minimal acceptable for internal
consistency of multi-item scales, others accept 0.6 or 0.5–0.6 for
Figure 6. Structural Equation Model of pH1N1 vaccination uptake. Numbers represent the standardized parameters (b). R2 represents the
explained variance of the dependent variables by the predictors (Sample size N= 896). Ovals represent latent variables, rectangles represent observed
variables.
doi:10.1371/journal.pone.0017713.g006
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preliminary research as the cut-off point [56]. Other than
dimensionality concerns, lower a can reflect too few items
comprising the putative scale [73]. This is more likely for complex
variables, such as social norms which have a broad spectrum of
elements. Though less than perfect, measurement errors can be
reduced by incorporating the items as a latent variable in SEM
[55], an approach we adopted. Additionally, collinearity between
exogenous indicators, such as social norms and perceived benefit
can be potentially problematic, perhaps lowering the accuracy of
SEM estimation. However, since high associations between
measures of the constructs were not observed (Table 3) then
collinearity-related error is probably small [74]. Despite being
randomly selected for the parent study, subjects of this study were
not randomly selected from the general population, although
demographics suggest the current sample is comparable to the
Hong Kong general population [61] (Table 2). Moreover, subject
recruitment was based on voluntariness and all data were self-
reported. All could cause social desirability and selection bias, so
caution is needed before extrapolation to the general population.
Also refusal at follow-up could have influenced patterns of
responses. Our study examined public decision-making regarding
a novel influenza pandemic vaccine. Our findings may not apply
to vaccination against seasonal influenza due to numerous
differences in beliefs towards the vaccination. For example,
although perceived low risk remains the major reasons for refusing
vaccination against seasonal influenza as in our study, vaccine
safety is seldom cited as a barrier [28,29] whereas we found that
about one third of respondents had vaccine safety concerns.
Cultural differences in influenza and vaccination-related beliefs
are possible [75], but these differences may gradually diminish
with the increasing identical news information available through
the three dominant news agencies and common public health
strategies being increasingly universal. Related stories, such as use
of preservatives and adjuvants in vaccine manufacture may
enhance knowledge and reduce trust in product safety [76]. The
role of media remains much under-researched in this regard.
Finally, data was insufficient to reliably report the reasons for
pH1N1 vaccination uptake among the population.
Nonetheless, compared with other cross-sectional studies
[12,15–27], the longitudinal design of this study strengthens
understanding of influences on population decision-making for
pandemic influenza vaccination uptake and represents a step
forward in this area of research. This study is novel in linking
theoretically derived, vaccination-related cognitions to subsequent
influenza vaccination behaviour, and exemplifies that within the
Hong Kong Chinese culture, social norms and action planning are
far more influential than intention in predicting vaccination
behaviour.
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